Valuation: ResMed, Inc.

Capitalization 3.32TCr 2.83TCr 2.62TCr 2.46TCr 4.59TCr 3,08700Cr 4.68TCr 31TCr 12TCr 1,48300Cr 12TCr 12TCr 5,28200Cr P/E ratio 2026 *
21.6x
P/E ratio 2027 * 19.4x
Enterprise value 3.21TCr 2.74TCr 2.53TCr 2.39TCr 4.44TCr 2,98800Cr 4.53TCr 30TCr 12TCr 1,43500Cr 12TCr 12TCr 5,11300Cr EV / Sales 2026 *
5.7x
EV / Sales 2027 * 5.17x
Free-Float
76.64%
Yield 2026 *
1.06%
Yield 2027 * 1.17%
1 day+0.39%
1 week+2.13%
Current month+1.96%
1 month-4.70%
3 months-9.35%
6 months-15.86%
Current year-4.98%
1 week 222.35
Extreme 222.35
234.9
1 month 218.39
Extreme 218.39
235.8
Current year 218.39
Extreme 218.39
277.67
1 year 202
Extreme 202
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 55.43
Extreme 55.43
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 59 01/01/2006
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5d. change 1-year change 3-years change Capi.($)
+0.39%+2.13%+6.95%+2.55% 3.32TCr
-0.87%+0.95%+13.23%-13.93% 18TCr
-0.95%-0.32%-8.71%+71.49% 16TCr
-1.75%-0.79%+0.47%-24.12% 13TCr
+0.83%-1.64%-34.03%+21.80% 9.18TCr
+1.15%+4.95%-13.23%-30.70% 4.95TCr
-1.62%-3.92%+12.20%-5.27% 4.49TCr
+0.37%+4.02%+16.51%-9.19% 3.34TCr
-0.29%-0.36%+12.02%-16.94% 3.25TCr
+0.74%+5.18%-1.61%+5.90% 3.14TCr
Average -0.20%+1.19%+0.38%+0.16% 7.95TCr
Weighted average by Cap. -0.56%+0.66%-1.26%+6.66%

Financials

2026 *2027 *
Net sales 564.09Cr 480.54Cr 444.73Cr 418.74Cr 779.97Cr 52TCr 795.95Cr 5.22TCr 2.04TCr 25TCr 2.12TCr 2.07TCr 90TCr 606.15Cr 516.38Cr 477.89Cr 449.97Cr 838.14Cr 56TCr 855.31Cr 5.61TCr 2.19TCr 27TCr 2.27TCr 2.23TCr 96TCr
Net income 154.05Cr 131.23Cr 121.45Cr 114.35Cr 213Cr 14TCr 217.37Cr 1.42TCr 557.49Cr 6.88TCr 578.1Cr 565.84Cr 25TCr 172.16Cr 146.66Cr 135.73Cr 127.8Cr 238.05Cr 16TCr 242.92Cr 1.59TCr 623.03Cr 7.69TCr 646.07Cr 632.37Cr 27TCr
Net Debt -106.42Cr -91Cr -84Cr -79Cr -147.15Cr -9.9TCr -150.16Cr -984.26Cr -385.12Cr -4.75TCr -399.36Cr -390.9Cr -17TCr -186.8Cr -159.13Cr -147.27Cr -138.67Cr -258.29Cr -17TCr -263.58Cr -1.73TCr -676.02Cr -8.34TCr -701.01Cr -686.15Cr -30TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
10/26/10 228.87 $ +0.39% 8,43,992
09/26/09 227.98 $ -1.18% 11,41,069
08/26/08 230.70 $ +2.06% 11,16,521
07/26/07 226.05 $ +0.50% 10,30,133
06/26/06 224.93 $ +0.37% 5,98,921
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
228.87USD
Average target price
296.53USD
Spread / Average Target
+29.56%

Quarterly revenue - Rate of surprise